Tamtuvetmab (AT-005) is a caninized version of blontuvetmab targeting CD52, designed specifically for veterinary use. This therapeutic antibody has demonstrated an ability to increase progression-free survival (PFS) and shows in vivo efficacy in canine subjects with naive T-cell lymphoma (LSA). Tamtuvetmab has received approval for veterinary applications, underscoring its relevance and utility in the treatment of lymphoma in dogs.
Tamtuvetmab (AT-005) is a caninized version of blontuvetmab targeting CD52, designed specifically for veterinary use. This therapeutic antibody has demonstrated an ability to increase progression-free survival (PFS) and shows in vivo efficacy in canine subjects with naive T-cell lymphoma (LSA). Tamtuvetmab has received approval for veterinary applications, underscoring its relevance and utility in the treatment of lymphoma in dogs.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: